Your session is about to expire
← Back to Search
Tai Chi for Multiple Myeloma
N/A
Waitlist Available
Led By Kristinna Gowin, DO
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of Multiple Myeloma planned to undergo bone marrow transplant
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 100
Awards & highlights
Study Summary
This trial will test whether Tai Chi Easy (TCE) can help improve the immune system function of multiple myeloma patients undergoing stem cell transplantation, as well as explore the impact of TCE on health-related quality of life.
Who is the study for?
This trial is for English-speaking adults over 18 with Multiple Myeloma who are about to have a bone marrow transplant and can do basic physical activities (ECOG status 0-1). They must be able to attend Tai Chi sessions. People with recent fainting, severe depression or anxiety, regular Tai Chi/Qi Gong/Yoga practice, chronic dizziness, frequent falls, or serious neuropathy cannot join.Check my eligibility
What is being tested?
The TOTOM Trial is testing whether practicing Tai Chi Easy can improve immune function and quality of life in patients undergoing stem cell transplants for Multiple Myeloma. Participants will attend designated Tai Chi training sessions as part of the study.See study design
What are the potential side effects?
Tai Chi Easy is generally considered safe but may include risks like muscle soreness or strain. Since it's a gentle form of exercise, serious side effects are not common.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have Multiple Myeloma and am planning to have a bone marrow transplant.
Select...
I am 18 years old or older.
Select...
I am fully active or can carry out light work.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 100
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 100
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Determine NK cell activity
Determine immune function
Determine natural killer cell phenotype
Trial Design
1Treatment groups
Experimental Treatment
Group I: Tai Chi Easy InterventionExperimental Treatment1 Intervention
Tai Chi Easy: TCE is a standardized protocol used in several prior studies. TCE has been manualized and has a formal training program for instructors. The protocol is taught as a series of repeated and simple-to-learn movements. Patients will receive two 30-minute small group training sessions (Via Zoom) within 7 days of their scheduled transplant. After the training has been completed the participant will be provided with written (via manual) and electronic (DVD, MP3 file download) materials to continue with self-direct practice throughout the duration of the study.
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
514 Previous Clinical Trials
148,259 Total Patients Enrolled
7 Trials studying Multiple Myeloma
839 Patients Enrolled for Multiple Myeloma
Kristinna Gowin, DOPrincipal InvestigatorUniversity of Arizona
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe nerve pain or damage.I have Multiple Myeloma and am planning to have a bone marrow transplant.I have been diagnosed with major depression or an anxiety disorder.I have fainted in the last 60 days.I am 18 years old or older.I can attend the required training session for the study.You currently practice Tai Chi, QiQong, or Yoga at least once a week or more.I suffer from long-term dizziness or balance problems.I have fallen more than twice in the last year.I am fully active or can carry out light work.
Research Study Groups:
This trial has the following groups:- Group 1: Tai Chi Easy Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are currently in the experimental treatment program?
"Affirmative. According to information hosted on clinicaltrials.gov, this research is currently accepting participants and was initially advertised on March 11th 2021. The recruitment process seeks 20 individuals from 1 medical centre for the duration of the study."
Answered by AI
Are there vacancies in this clinical trial that participants can apply for?
"According to clinicaltrials.gov, this medical inquiry is currently enlisting patients with the initial posting on March 11th 2021 and most recent update being May 2nd 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger